Abaloparatide Increases Distal Femur Bone Mineral Density Post-Total Knee Arthroplasty
Background: Osteoporosis is common in joint replacement patients and increases adverse outcome risk. Data indicate that total knee arthroplasty (TKA) causes distal femur bone loss. We hypothesized that abaloparatide (ABL) would mitigate this loss. The study’s purpose was to evaluate the effect of ABL initiated before T...